This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
In a move that will significantly expand its opportunities in the molecular diagnostics field and increase its consumables sales, Agilent said last week that it would acquire Stratagene in a deal valued at roughly $246 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.